Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases.


Mitochondria fragmentation destabilizes mitochondrial membranes, promotes oxidative stress and facilitates cell death, thereby contributing to the development and the progression of several mitochondria-related diseases. Accordingly, compounds that reverse mitochondrial fragmentation could have therapeutic potential in treating such diseases. BGP-15, a… (More)
DOI: 10.1016/j.bcp.2018.01.038


  • Presentations referencing similar topics